News & Views
Laboratory scientists develop new cancer-killing drug
May 11 2010
Described as a "breakthrough" by the Samuel Waxman Cancer Research Foundation, the treatment is a drug that targets an oncogene known as BCL6.
Associate professor of medicine at Weill Cornell Medical College in New York City Dr Alexander MacKerell said BCL6 is a protein that controls "thousands of other genes".
"Because of that, it has a very profound impact on cells and is required for lymphoma cells to survive and multiply," he explained.
According to the expert, current chemotherapy methods for large B cell lymphomas cure 60 per cent of patients, but it is hoped a larger number can be saved with the new medication.
It is possible that the drug may eventually negate the need for toxic treatments completely, he added.
Last month, laboratory scientists at Fox Chase Cancer Center revealed they may have found an innovative way to screen early for ovarian tumours.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark